Intrepid Capital Management Inc. purchased a new stake in Cerner Co. (NASDAQ:CERN) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 11,800 shares of the company’s stock, valued at approximately $865,000.
A number of other institutional investors have also made changes to their positions in CERN. Dimensional Fund Advisors LP increased its holdings in Cerner by 25.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,502,329 shares of the company’s stock valued at $78,781,000 after buying an additional 307,694 shares during the period. Geode Capital Management LLC boosted its stake in shares of Cerner by 7.8% in the 4th quarter. Geode Capital Management LLC now owns 4,747,793 shares of the company’s stock valued at $248,593,000 after purchasing an additional 342,029 shares in the last quarter. Robeco Institutional Asset Management B.V. boosted its stake in shares of Cerner by 273.2% in the 1st quarter. Robeco Institutional Asset Management B.V. now owns 62,193 shares of the company’s stock valued at $3,559,000 after purchasing an additional 45,528 shares in the last quarter. Victory Capital Management Inc. boosted its stake in shares of Cerner by 6.3% in the 1st quarter. Victory Capital Management Inc. now owns 64,356 shares of the company’s stock valued at $3,682,000 after purchasing an additional 3,787 shares in the last quarter. Finally, Mn Services Vermogensbeheer B.V. boosted its stake in shares of Cerner by 5.8% in the 1st quarter. Mn Services Vermogensbeheer B.V. now owns 53,127 shares of the company’s stock valued at $3,039,000 after purchasing an additional 2,900 shares in the last quarter. 83.22% of the stock is currently owned by hedge funds and other institutional investors.
Shares of NASDAQ CERN opened at $68.03 on Friday. The firm’s 50-day simple moving average is $70.10 and its 200 day simple moving average is $67.02. The company has a market cap of $21.65 billion, a price-to-earnings ratio of 30.78, a price-to-earnings-growth ratio of 1.90 and a beta of 0.92. The company has a quick ratio of 2.50, a current ratio of 2.52 and a debt-to-equity ratio of 0.22. Cerner Co. has a 12-month low of $48.78 and a 12-month high of $76.47.
Cerner (NASDAQ:CERN) last issued its quarterly earnings results on Wednesday, July 24th. The company reported $0.60 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.58 by $0.02. The business had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.44 billion. Cerner had a net margin of 10.75% and a return on equity of 15.14%. The firm’s quarterly revenue was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.62 EPS. On average, equities analysts expect that Cerner Co. will post 2.43 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 9th. Investors of record on Wednesday, September 25th will be given a dividend of $0.18 per share. The ex-dividend date of this dividend is Tuesday, September 24th. This represents a $0.72 annualized dividend and a yield of 1.06%. Cerner’s dividend payout ratio (DPR) is 32.58%.
In other Cerner news, EVP John Peterzalek sold 27,484 shares of the company’s stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $72.11, for a total transaction of $1,981,871.24. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Julie L. Gerberding sold 7,928 shares of the company’s stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $71.82, for a total transaction of $569,388.96. The disclosure for this sale can be found here. In the last quarter, insiders have sold 288,377 shares of company stock worth $19,427,390. 0.75% of the stock is owned by corporate insiders.
Several equities research analysts have recently commented on the stock. Wells Fargo & Co boosted their target price on shares of Cerner from $72.00 to $80.00 and gave the company an “outperform” rating in a research note on Thursday, July 25th. ValuEngine downgraded shares of Cerner from a “buy” rating to a “hold” rating in a research note on Wednesday, September 4th. BidaskClub downgraded shares of Cerner from a “sell” rating to a “strong sell” rating in a research note on Friday, September 6th. Jefferies Financial Group downgraded shares of Cerner from a “buy” rating to a “hold” rating and boosted their target price for the company from $69.00 to $75.00 in a research note on Friday, August 23rd. Finally, Zacks Investment Research downgraded shares of Cerner from a “buy” rating to a “hold” rating and set a $77.00 target price on the stock. in a research note on Monday, July 29th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and eleven have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $74.73.
Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Read More: How to calculate compound interest
Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner Co. (NASDAQ:CERN).
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.